Health Catalyst HCAT Stock Issued During Period Value Acquisitions
Stock Issued During Period Value Acquisitions at other companies
Other financials
Where this comes from
Reported directly by Health Catalyst in its filing.
Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueAcquisitions.
The official record: Health Catalyst’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Health Catalyst's stock issued during period value acquisitions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Health Catalyst's stock issued during period value acquisitions?
- Health Catalyst (HCAT) reported stock issued during period value acquisitions of $0 in Q1 2026.
- How has Health Catalyst's stock issued during period value acquisitions changed year-over-year?
- Health Catalyst's stock issued during period value acquisitions decreased by 100.0% year-over-year, from $31.58M to $0.
- What is the long-term trend for Health Catalyst's stock issued during period value acquisitions?
- Over 2 years (2021 to 2024), Health Catalyst's stock issued during period value acquisitions has grown at a -23.9% compound annual growth rate (CAGR), from $43.1M to $24.93M.
- What does stock issued during period value acquisitions mean?
- This represents the value of common stock issued as consideration for business acquisitions rather than cash payments. It provides insight into the company's strategy for inorganic growth and the use of equity as a currency for expansion. Investors use this to assess the dilution impact on existing shareholders relative to the value gained from the acquisition.